Yikon Genomics Inc has announced the availability of an At-Home Screening Kit for Detection of IgM/IgG Antibody to SARS-CoV-2. The screening test uses a simple finger stick procedure to test the presence of the aforementioned antibodies in the blood stream, making it possible to detect current or recent viral infections of COVID-19. The kit is available for individual purchase or for bulk orders. 

With a sensitivity of 95.04% and a specificity of  100%, this Kit can be used to confidently screen for the antibodies. The validation results indicate that the test kits can accurately assist with the diagnosis of new coronavirus infections and are not affected by hepatitis B virus (HBV), influenza A (Flu A), influenza B virus (Flu B), and respiratory syncytial virus (RSV).

"We are relieved to be able to provide this kit to people across the world in response to the Corona Virus pandemic," expresses Brandon Hensinger, Global Vice President of Yikon Genomics. "We hope that this test can improve the number of patients getting screened, and also can provide peace of mind to people throughout the world"

The kit can be purchased at www.TheCoronaVirusTestKit.com .

Yikon Genomics is a global genetic laboratory, responsible for introducing innovative solutions in reproductive genetics, oncology, life sciences, and more. They are most recently responsible for the launch of the world's first clinical non-invasive PGT-A.

###

For more information, please contact Brandon Hensinger at  brandon@yikonglobal.com or 919-345-1087